Pharmaceutical framework discount agreements under Section 130a(8) SGB V

Summary

Kaufmännische Krankenkasse (KKH), acting for itself and five other German statutory health insurers, is seeking active-ingredient-based discount agreements for finished medicines supplied to their insured members. The requirement is divided into 85 lots by active ingredient, strength, dosage form, pack size and insurer group; most lots concern prescription medicines, while designated lots concern over-the-counter medicines. The planned contract period is 1 July 2027 to 30 June 2029, with no guaranteed purchase volume.